Metagenomi Therapeutics, Inc. - Common Stock — 四半期財務統計 (NASDAQ:MGX) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -26.28 M-22.84 M-21.25 M-21.25 M-23.55 M-21.18 M -87.22 M 投資活動によるキャッシュフロー 28.55 M24.73 M19.07 M27.36 M32.37 M3.99 M 82.79 M 財務活動によるキャッシュフロー 0-77 K-166 K-187 K74 K-27 K -306 K フリーキャッシュフロー -26.28 M-22.84 M-21.38 M-21.33 M-23.63 M-21.2 M -87.54 M

ニュース

Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates

Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates

Buy These 3 Best Stocks Now, According to Top Wall Street Analysts, 3/6/2026 - TipRanks.com

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

What you should know about the owners of US TikTok

Oracle says data center outage causing issues faced by US TikTok users

MGXリソース、2026年第2四半期は多角化戦略に注力

Earnings call transcript: MGX Resources Q2 2026 focuses on diversification

TikTok reaches deal for new US joint venture to avoid American ban

メタゲノミ、社名変更し血友病A遺伝子治療プログラムを前進